Koers Adaptive Biotechnologies Corporation
Aandelen
ADPT
US00650F1093
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,5 USD | -1,69% | +16,28% | -28,57% |
Omzet 2024 * | 170 mln. 158 mln. | Omzet 2025 * | 210 mln. 194 mln. | Marktkapitalisatie | 516 mln. 478 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -189 mln. -175 mln. | Nettowinst (verlies) 2025 * | -149 mln. -138 mln. | EV/omzet 2024 * | 2,94 x |
Nettoliquiditeiten 2024 * | 14,91 mln. 13,83 mln. | Nettoliquiditeiten 2025 * | 7,88 mln. 7,31 mln. | EV/omzet 2025 * | 2,42 x |
K/w-verhouding 2024 * |
-2,72
x | K/w-verhouding 2025 * |
-3,21
x | Werknemers | 709 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,92% |
Recentste transcriptie over Adaptive Biotechnologies Corporation
1 dag | -1,69% | ||
1 week | +16,28% | ||
Lopende maand | +33,59% | ||
1 maand | +16,28% | ||
3 maanden | -10,71% | ||
6 maanden | -0,28% | ||
Lopend jaar | -28,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harlan Robins
FOU | Founder | 51 | 08-09-09 |
Chad Robins
CEO | Chief Executive Officer | 49 | 08-09-09 |
Kyle Piskel
DFI | Director of Finance/CFO | 40 | 28-10-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 01-02-13 |
Peter Neupert
BRD | Director/Board Member | 68 | 01-01-14 |
Michael Pellini
BRD | Director/Board Member | 58 | 13-02-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.68% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 3,5 | -1,69% | 1 221 825 |
09-05-24 | 3,56 | +11,95% | 1 417 130 |
08-05-24 | 3,18 | +2,25% | 2 147 360 |
07-05-24 | 3,11 | -3,42% | 1 110 526 |
06-05-24 | 3,22 | +6,98% | 1 474 457 |
uitgestelde koers Nasdaq, 10 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-28,57% | 516 mln. | |
-27,67% | 9,87 mld. | |
-17,30% | 2,74 mld. | |
-11,15% | 2,24 mld. | |
-22,32% | 1,63 mld. | |
+59,69% | 1,39 mld. | |
+23,58% | 772 mln. | |
-1,31% | 760 mln. | |
+5,37% | 310 mln. | |
+12,46% | 219 mln. |